Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.

<h4>Background</h4>Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disorder. The American College of Medical Genetics has recently recommended routine carrier screening for SMA because of the high carrier frequency (1 in 25-50) as well as the severity o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yi-Ning Su, Chia-Cheng Hung, Shin-Yu Lin, Fang-Yi Chen, Jimmy P S Chern, Chris Tsai, Tai-Sheng Chang, Chih-Chao Yang, Hung Li, Hong-Nerng Ho, Chien-Nan Lee
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2011
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/29dbdcac33444f0684ed8ebe44404fb7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:29dbdcac33444f0684ed8ebe44404fb7
record_format	dspace
spelling	oai:doaj.org-article:29dbdcac33444f0684ed8ebe44404fb72021-11-18T06:58:13ZCarrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.1932-620310.1371/journal.pone.0017067https://doaj.org/article/29dbdcac33444f0684ed8ebe44404fb72011-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21364876/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disorder. The American College of Medical Genetics has recently recommended routine carrier screening for SMA because of the high carrier frequency (1 in 25-50) as well as the severity of that genetic disease. Large studies are needed to determine the feasibility, benefits, and costs of such a program.<h4>Methods and findings</h4>This is a prospective population-based cohort study of 107,611 pregnant women from 25 counties in Taiwan conducted during the period January 2005 to June 2009. A three-stage screening program was used: (1) pregnant women were tested for SMA heterozygosity; (2) if the mother was determined to be heterozygous for SMA (carrier status), the paternal partner was then tested; (3) if both partners were SMA carriers, prenatal diagnostic testing was performed. During the study period, a total of 2,262 SMA carriers with one copy of the SMN1 gene were identified among the 107,611 pregnant women that were screened. The carrier rate was approximately 1 in 48 (2.10%). The negative predictive value of DHPLC coupled with MLPA was 99.87%. The combined method could detect approximately 94% of carriers because most of the cases resulted from a common single deletion event. In addition, 2,038 spouses were determined to be SMA carriers. Among those individuals, 47 couples were determined to be at high risk for having offspring with SMA. Prenatal diagnostic testing was performed in 43 pregnant women (91.49%) and SMA was diagnosed in 12 (27.91%) fetuses. The prevalence of SMA in our population was 1 in 8,968.<h4>Conclusion</h4>The main benefit of SMA carrier screening is to reduce the burden associated with giving birth to an affected child. In this study, we determined the carrier frequency and genetic risk and provided carrier couples with genetic services, knowledge, and genetic counseling.Yi-Ning SuChia-Cheng HungShin-Yu LinFang-Yi ChenJimmy P S ChernChris TsaiTai-Sheng ChangChih-Chao YangHung LiHong-Nerng HoChien-Nan LeePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 2, p e17067 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Yi-Ning Su Chia-Cheng Hung Shin-Yu Lin Fang-Yi Chen Jimmy P S Chern Chris Tsai Tai-Sheng Chang Chih-Chao Yang Hung Li Hong-Nerng Ho Chien-Nan Lee Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
description	<h4>Background</h4>Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disorder. The American College of Medical Genetics has recently recommended routine carrier screening for SMA because of the high carrier frequency (1 in 25-50) as well as the severity of that genetic disease. Large studies are needed to determine the feasibility, benefits, and costs of such a program.<h4>Methods and findings</h4>This is a prospective population-based cohort study of 107,611 pregnant women from 25 counties in Taiwan conducted during the period January 2005 to June 2009. A three-stage screening program was used: (1) pregnant women were tested for SMA heterozygosity; (2) if the mother was determined to be heterozygous for SMA (carrier status), the paternal partner was then tested; (3) if both partners were SMA carriers, prenatal diagnostic testing was performed. During the study period, a total of 2,262 SMA carriers with one copy of the SMN1 gene were identified among the 107,611 pregnant women that were screened. The carrier rate was approximately 1 in 48 (2.10%). The negative predictive value of DHPLC coupled with MLPA was 99.87%. The combined method could detect approximately 94% of carriers because most of the cases resulted from a common single deletion event. In addition, 2,038 spouses were determined to be SMA carriers. Among those individuals, 47 couples were determined to be at high risk for having offspring with SMA. Prenatal diagnostic testing was performed in 43 pregnant women (91.49%) and SMA was diagnosed in 12 (27.91%) fetuses. The prevalence of SMA in our population was 1 in 8,968.<h4>Conclusion</h4>The main benefit of SMA carrier screening is to reduce the burden associated with giving birth to an affected child. In this study, we determined the carrier frequency and genetic risk and provided carrier couples with genetic services, knowledge, and genetic counseling.
format	article
author	Yi-Ning Su Chia-Cheng Hung Shin-Yu Lin Fang-Yi Chen Jimmy P S Chern Chris Tsai Tai-Sheng Chang Chih-Chao Yang Hung Li Hong-Nerng Ho Chien-Nan Lee
author_facet	Yi-Ning Su Chia-Cheng Hung Shin-Yu Lin Fang-Yi Chen Jimmy P S Chern Chris Tsai Tai-Sheng Chang Chih-Chao Yang Hung Li Hong-Nerng Ho Chien-Nan Lee
author_sort	Yi-Ning Su
title	Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
title_short	Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
title_full	Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
title_fullStr	Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
title_full_unstemmed	Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
title_sort	carrier screening for spinal muscular atrophy (sma) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
publisher	Public Library of Science (PLoS)
publishDate	2011
url	https://doaj.org/article/29dbdcac33444f0684ed8ebe44404fb7
work_keys_str_mv	AT yiningsu carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT chiachenghung carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT shinyulin carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT fangyichen carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT jimmypschern carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT christsai carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT taishengchang carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT chihchaoyang carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT hungli carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT hongnerngho carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy AT chiennanlee carrierscreeningforspinalmuscularatrophysmain107611pregnantwomenduringtheperiod20052009aprospectivepopulationbasedcohortstudy
_version_	1718424089351159808

Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.

Ejemplares similares